Abstract
AbstractA multitude of approaches will be required to respond to the threat posed by the emergence and spread of antibiotic resistant pathogens. Bacteriocins have gained increasing attention as a possible alternative to antibiotics, as such peptide antimicrobials have mechanisms of action different from antibiotics and are therefore equally potent against antibiotic resistant bacteria as their susceptible counterparts. A group of bacteriocins known as saposin-like bacteriocins is believed to act directly on the bacterial membrane. Based on seven saposin-like leaderless bacteriocins, we have constructed a library of hybrid peptides containing all combinations of the N- and C-terminal halves of the native bacteriocins. All hybrid peptides were synthesized using in vitro protein expression and assayed for antimicrobial activity towards several pathogens. Of the 42 hybrid peptides, antimicrobial activity was confirmed for 11 novel hybrid peptides. Furthermore, several of the hybrid peptides exhibited altered antimicrobial spectra and apparent increase in potency compared to the peptides from which they were derived. The most promising hybrid, termed ISP26, was then obtained synthetically and shown to inhibit most of the Gram-positive species tested, including opportunistic pathogens and food spoilage bacteria. Additionally, ISP26 was shown to inhibit Acinetobacter, a species of Gram-negative bacteria frequently isolated from nosocomial infections. The activity of the hybrid library provides valuable insights into the design and screening of new active bacteriocins.
Funder
Norwegian University of Life Sciences
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Murray CJL, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
2. O’Neill J (2014) Review on antimicrobial resistance antimicrobial resistance: tackling a crisis for the health and wealth of nations. Wellcome Trust and the UK Department of Health. https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf. Accessed 3 Jan 2024
3. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Division of Healthcare Quality Promotion. (Ed.). (2022). COVID-19: U.S. impact on antimicrobial resistance, special report 2022 (cdc:119025). https://stacks.cdc.gov/view/cdc/119025
4. Sugden R, Kelly R, Davies S (2016) Combatting antimicrobial resistance globally. Nat Microbiol 1:1–2. https://doi.org/10.1038/nmicrobiol.2016.187
5. Kuhar I, Žgur-Bertok D (1999) Transcription regulation of the colicin K cka gene reveals induction of colicin synthesis by differential responses to environmental signals. J Bacteriol 181:7373–7380. https://doi.org/10.1128/jb.181.23.7373-7380.1999